A photographic comparison of Seleno-Trastuzumab, Trastuzumab, and Selenite on inhibition of the Her2+ human breast cancer cell line BT-474.

Julian Spallholz (Speaker)

Activity: Talk or presentationOther

PeriodOct 1 2013Oct 31 2013
Held atSelenium 2013
Degree of RecognitionInternational